Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q1 FY22 results · Apr–Jun 2021
Amrutanjan Health Care reported revenue from operations of ₹78.21 crore (up 67.8% from Q1 FY21) and net profit of ₹12.06 crore (up 87.6% from Q1 FY21) for Q1 FY22 (Apr–Jun 2021), on a standalone basis.
| Item | Q1 FY22 | Q1 FY21 | YoY | Q4 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 78.21 | 46.62 | +67.8% | 94.02 | −16.8% |
| Other income | 2.74 | 2.05 | +33.9% | 2.68 | +2.2% |
| Total income | 80.95 | 48.66 | +66.3% | 96.70 | −16.3% |
| Profit before tax | 16.29 | 8.66 | +88.0% | 13.71 | +18.8% |
| Net profit for the period | 12.06 | 6.43 | +87.6% | 10.23 | +17.9% |
| EPS, basic (₹) | 4.12 | 2.20 | +87.3% | 3.50 | +17.7% |
| Net margin (%) | 15.4 | 13.8 | 10.9 |
Standalone
- Filed with BSE
- 17 Aug 2021, 13:58 IST
- Board meeting
- 14 Aug 2021
- Period
- 01 Apr 2021 to 30 Jun 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE